{"id":"https://openalex.org/W2033780802","doi":"https://doi.org/10.1159/000216471","title":"High-Dose Cytosine Arabinoside and Mitoxantrone: Preliminary Results of a Pilot Study with Sequential Application (S-HAM) Indicating a High Antileukemic Activity in Refractory Acute Leukemias","display_name":"High-Dose Cytosine Arabinoside and Mitoxantrone: Preliminary Results of a Pilot Study with Sequential Application (S-HAM) Indicating a High Antileukemic Activity in Refractory Acute Leukemias","publication_year":2009,"publication_date":"2009-04-27","ids":{"openalex":"https://openalex.org/W2033780802","doi":"https://doi.org/10.1159/000216471","mag":"2033780802","pmid":"https://pubmed.ncbi.nlm.nih.gov/3283619"},"language":"en","primary_location":{"id":"doi:10.1159/000216471","doi":"https://doi.org/10.1159/000216471","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000216471","pdf_url":null,"source":{"id":"https://openalex.org/S4210228507","display_name":"Onkologie","issn_l":"0378-584X","issn":["0378-584X","1423-0240"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onkologie","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108511937","display_name":"Wolfgang Hiddemann","orcid":"https://orcid.org/0000-0003-3634-2558","observed_orcids":["https://orcid.org/0000-0003-3634-2558","https://orcid.org/0000-0001-7208-4117"]},"institutions":[{"id":"https://openalex.org/I22465464","display_name":"University of M\u00fcnster","ror":"https://ror.org/00pd74e08","country_code":"DE","type":"education","lineage":["https://openalex.org/I22465464"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W. Hiddemann","raw_affiliation_strings":["Department of Internal Medicine, University of M\u00fcnster, FRG","Department of Internal Medicine, U. University of M\u00fcnster, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University of M\u00fcnster, FRG","institution_ids":["https://openalex.org/I22465464"]},{"raw_affiliation_string":"Department of Internal Medicine, U. University of M\u00fcnster, FRG","institution_ids":["https://openalex.org/I22465464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071091625","display_name":"Thomas B\u00fcchner","orcid":"https://orcid.org/0000-0003-1803-3196","observed_orcids":["https://orcid.org/0000-0003-1803-3196"]},"institutions":[{"id":"https://openalex.org/I22465464","display_name":"University of M\u00fcnster","ror":"https://ror.org/00pd74e08","country_code":"DE","type":"education","lineage":["https://openalex.org/I22465464"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"T. B\u00fcchner","raw_affiliation_strings":["Department of Internal Medicine, U. University of M\u00fcnster, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, U. University of M\u00fcnster, FRG","institution_ids":["https://openalex.org/I22465464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002716547","display_name":"Monika Essink","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I22465464","display_name":"University of M\u00fcnster","ror":"https://ror.org/00pd74e08","country_code":"DE","type":"education","lineage":["https://openalex.org/I22465464"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Essink","raw_affiliation_strings":["Department of Internal Medicine, U. University of M\u00fcnster, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, U. University of M\u00fcnster, FRG","institution_ids":["https://openalex.org/I22465464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088803850","display_name":"Olaf Koch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I22465464","display_name":"University of M\u00fcnster","ror":"https://ror.org/00pd74e08","country_code":"DE","type":"education","lineage":["https://openalex.org/I22465464"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"O. Koch","raw_affiliation_strings":["Department of Internal Medicine, U. University of M\u00fcnster, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, U. University of M\u00fcnster, FRG","institution_ids":["https://openalex.org/I22465464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113692374","display_name":"Werner Stenzinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I22465464","display_name":"University of M\u00fcnster","ror":"https://ror.org/00pd74e08","country_code":"DE","type":"education","lineage":["https://openalex.org/I22465464"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W. Stenzinger","raw_affiliation_strings":["Department of Internal Medicine, U. University of M\u00fcnster, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, U. University of M\u00fcnster, FRG","institution_ids":["https://openalex.org/I22465464"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112818608","display_name":"J\u00fcrgen van de Loo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. van de Loo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.218,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.60307623,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"11","issue":"1","first_page":"10","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.06319999694824219,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.9940000176429749},{"id":"https://openalex.org/keywords/refractory-acute-leukemia","display_name":"refractory acute leukemia","score":0.8240000009536743},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.9380000233650208},{"id":"https://openalex.org/keywords/antileukemic-activity","display_name":"antileukemic activity","score":0.8949999809265137},{"id":"https://openalex.org/keywords/relapsed-acute-leukemia","display_name":"relapsed acute leukemia","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8219097852706909},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.7896037101745605},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.5092712640762329},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.09812197089195251},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.0897233784198761}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007945","descriptor_name":"Leukemia, Lymphoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1159/000216471","doi":"https://doi.org/10.1159/000216471","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000216471","pdf_url":null,"source":{"id":"https://openalex.org/S4210228507","display_name":"Onkologie","issn_l":"0378-584X","issn":["0378-584X","1423-0240"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onkologie","raw_type":"journal-article"},{"id":"pmid:3283619","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3283619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onkologie","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2033902902","https://openalex.org/W7540448","https://openalex.org/W1017343404","https://openalex.org/W24153442","https://openalex.org/W1591796471","https://openalex.org/W2074821846","https://openalex.org/W2410504990","https://openalex.org/W1991205570","https://openalex.org/W2048312112","https://openalex.org/W105092496"],"abstract_inverted_index":{"In":[0,151],"an":[1],"attempt":[2],"to":[3,37,199],"further":[4,146],"improve":[5],"on":[6,58,79,89,104,178],"the":[7,52,59,99,118,137,165,191,200],"encouraging":[8],"results":[9],"achieved":[10,123],"by":[11,66,85,161,164],"high-dose":[12],"cytosine":[13],"arabinoside":[14],"(HD":[15,109],"AraC)":[16,110],"and":[17,35,62,82,92,107,111,113,130,175],"mitoxantrone":[18,86],"(HAM)":[19],"in":[20],"refractory":[21],"acute":[22,43],"leukemias,":[23,44],"a":[24,124,145,156,186],"timely":[25],"modified":[26],"sequential":[27],"schedule":[28],"of":[29,46,136,153,181,190],"both":[30],"drugs":[31],"was":[32,74,102,159],"developed":[33],"(S-HAM)":[34],"applied":[36,75],"13":[38,119],"patients":[39,120,139,155],"with":[40,51,140,149],"far":[41],"advanced":[42],"8":[45,106,138],"whom":[47],"had":[48],"been":[49],"treated":[50],"original":[53,167],"HAM":[54,142,168,203],"protocol":[55,193],"before.":[56],"Based":[57],"cell":[60],"kinetic":[61],"pharmacokinetic":[63],"rationale":[64],"outlined":[65],"Capizzi":[67],"et":[68],"al.,":[69],"HD":[70],"AraC":[71],"3":[72,91,95],"g/m2":[73],"every":[76],"12":[77],"h":[78],"days":[80,90,96,105],"1":[81],"2":[83,127,131,152],"followed":[84],"10":[87,112],"mg/m2/day":[88],"4.":[93],"After":[94],"without":[97],"therapy":[98],"identical":[100],"sequence":[101],"repeated":[103],"9":[108,121],"11":[114],"(mitoxantrone),":[115],"respectively.":[116],"Of":[117],"(69%)":[122],"complete":[125,147],"remission,":[126],"were":[128,132],"resistant":[129],"early":[133],"deaths.":[134],"Six":[135],"prior":[141],"treatment":[143],"obtained":[144],"remission":[148,158],"S-HAM.":[150],"these":[154,171],"longer":[157],"induced":[160],"S-HAM":[162,192],"than":[163],"preceding":[166],"treatment.":[169],"Although":[170],"data":[172],"are":[173],"preliminary":[174],"need":[176],"confirmation":[177],"larger":[179],"numbers":[180],"patients,":[182],"they":[183],"strongly":[184],"suggest":[185],"high":[187],"antileukemic":[188],"activity":[189],"which":[194],"may":[195],"even":[196],"be":[197],"superior":[198],"previously":[201],"used":[202],"regimen.":[204]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}